Crossref
A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease
Current Trends in Biotechnology and Pharmacy · 09.06.2026 · 20 (2a) · 174-189
DOI: 10.5530/ctbp.2026.2s.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Trends in Biotechnology and Pharmacy, online erschienen am 09.06.2026. Verfasst von Ramya Sunkara und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sunkara, R., & Chimakurthy, J. (2026). A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease. Current Trends in Biotechnology and Pharmacy, 20(2a), 174-189. https://doi.org/10.5530/ctbp.2026.2s.14
Vancouver
Sunkara R, Chimakurthy J. A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease. Current Trends in Biotechnology and Pharmacy. 2026;20(2a):174-189. doi:10.5530/ctbp.2026.2s.14
BibTeX
@article{Sunkara2026,
author = {Sunkara, Ramya and Chimakurthy, Jithendra},
title = {A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease},
journal = {Current Trends in Biotechnology and Pharmacy},
year = {2026},
volume = {20},
number = {2a},
pages = {174--189},
doi = {10.5530/ctbp.2026.2s.14}
}
EUVIMED